A new retrospective study published in Obstetrics & Gynecology shows that robotics don’t improve benign hysterectomy outcomes and, in fact, increase cost of the surgery.
A new retrospective study published in Obstetrics & Gynecology shows that robotics don’t improve benign hysterectomy outcomes and, in fact, increase cost of the surgery.
The retrospective research-one of the first such nationwide studies-was derived from analysis of data in an insurance database. Information on surgical outcomes in more than 15,000 women who underwent minimally invasive benign hysterectomies from 2009 to 2010 was included. Half the patients had a robotic-assisted procedure and the other had conventional laparoscopy.
Researchers from the University of Texas Southwestern Medical Center found that complication rates were comparable for robotic (8.80%) versus conventional laparoscopic procedures (8.85%) Patients undergoing robotic hysterectomy were less likely to need a blood transfusion than those undergoing laparoscopy (P<.001), but more likely to have postoperative pneumonia (P=.005). Compared with laparoscopic hysterectomy, the cost of a robotic procedure averaged $2,489 more.
The authors note the need for more research on robotics, including the impact of the surgeon’s training on outcomes and longer-term patient follow-up on the procedures.
Be to sure to check out our special tech section in the October issue of Contemporary OB/GYN.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More